Skip to content

Comparison of loading dose alone versus standard pritchard regimen in severe preeclampsia patients for prevention of eclampsia-a randomized control trial

Comparison of loading dose alone versus standard pritchard regimen in severe preeclampsia patients for prevention of eclampsia a randomized control study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/083857
Enrollment
150
Registered
2025-04-02
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O141- Severe pre-eclampsia

Interventions

Intervention1: compares the effectiveness of a loading dose alone versus the standard Pritchard regimen in preventing eclampsia among severe preeclampsia patients. Participants are randomized into two

Sponsors

Department of Obstetrics and Gynaecology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient giving written informed consent will be taken Any intrapartum pregnant women with severe preeclampsia according to the ACOG criteria Systolic blood pressure of 160 mm Hg or higher or diastolic blood pressure of 110 mm Hg or higher on Two occasions atheist 6 hours apart) Systolic blood pressure of 160 mm Hg or more, ordiastolic blood pressure of 110 mm Hg or moreon two occasions at least 4 hours apart (unlessantihypertensive therapy is initiated before thistime)Thrombocytopenia (platelet count than 100,000109L Impaired liver function that is not accounted forby alternative diagnoses and as indicated byabnormally elevated blood concentrations of liverenzymes (to more than twice the upper limitnormal concentrations), or by severe persistentright upper quadrant or epigastric pain unre-sponsive to medications Renal insufficiency (serum creatinine concentration more than 1.1 mg/dL or a doubling of theserum creatinine concentration in the absence ofother renal disease) Pulmonary edema New-onset headache unresponsive to medicationand not accounted for by alternative diagnoses Chronic Hypertension patients with superimposed Severe Pre eclampsia

Exclusion criteria

Exclusion criteria: Not giving consent Eclampsia patients (defined as presence of new onset grandmas seizures in woman with preeclampsia ) Severe Preeclampsia with known case of epilepsy Women with plasma creatinine value 2 mg dl (impared renal function Patients who are on intercurrent MgSO4 therapy Women those that were already on magnesium sulphate prophylaxis at admission

Design outcomes

Primary

MeasureTime frame
The primary outcome will be the occurrence of seizures in the mothersTimepoint: from admission till 72 hrs post delivery

Secondary

MeasureTime frame
secondary outcomes will be conversion to the standard regime due to persistence of signs & symptoms of impending eclampsia, signs of magnesium intoxication like postpartum hemorrhage Timepoint: till 1 week

Countries

India

Contacts

Public ContactProf Pushpalata Sankhwar

King Georges Medical University Lucknow

sankhwar_pushpa@yahoo.com8874918425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026